Lisata Therapeutics, Inc. (LSTA)

NASDAQ: LSTA · Real-Time Price · USD

3.480

+0.130 (3.88%)

At close: Jun 8, 2026, 4:00 PM EDT

3.430

-0.050 (-1.44%)

After-hours: Jun 8, 2026, 6:09 PM EDT

Lisata Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13.06	15.96	16.21	22.59	32.15	24.65
Short-Term Investments	-	-	15.04	27.94	37.07	70.32
Cash & Short-Term Investments	13.06	15.96	31.25	50.54	69.23	94.97
Cash Growth	-49.45%	-48.93%	-38.17%	-27.00%	-27.11%	174.69%
Accounts Receivable	-	-	0.9	-	-	-
Other Current Assets	0.96	1.75	2.43	3.39	2.65	1.21
Total Current Assets	14.02	17.7	34.58	53.92	71.88	96.18
Net Property, Plant & Equipment	0.02	0.02	0.07	0.18	0.3	0.06
Other Intangible Assets	-	-	0.19	0.26	0.33	-
Other Long-Term Assets	0.02	0.02	0.16	0.33	0.53	0.76
Total Assets	14.06	17.74	35	54.69	73.03	97.01
Accounts Payable	0.51	1.02	1.28	2.42	2.66	1.93
Accrued Expenses	2.81	2.05	4.33	4.17	3.73	2.59
Total Current Liabilities	3.32	3.07	5.61	6.59	6.38	4.52
Other Long-Term Liabilities	0.07	0.07	0.07	0.21	0.33	0.49
Total Long-Term Liabilities	0.07	0.07	0.07	0.21	0.33	0.49
Total Liabilities	3.39	3.14	5.69	6.8	6.71	5.01
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Treasury Stock	-0.71	-0.71	-0.71	-0.71	-0.71	-0.71
Additional Paid-in Capital	580.79	580.24	578.42	576.97	574.55	546.04
Accumulated Other Comprehensive Income	-0.02	-0.04	-0.08	-0.04	-0.03	-0.07
Retained Earnings	-569.14	-564.65	-548.07	-528.08	-507.24	-453.02
Total Common Shareholders' Equity	10.93	14.86	29.57	48.15	66.58	92.25
Minority Interest	-0.25	-0.25	-0.25	-0.25	-0.25	-0.25
Shareholders' Equity	10.67	14.6	29.32	47.89	66.32	92
Total Liabilities & Equity	14.06	17.74	35	54.69	73.03	97.01
Net Cash (Debt)	13.06	15.96	31.25	50.54	69.23	94.97
Net Cash Growth	-18.15%	-48.93%	-38.17%	-27.00%	-27.11%	174.69%
Net Cash Per Share	1.49	1.84	3.75	6.26	13.36	25.75
Book Value	10.93	14.86	29.57	48.15	66.58	92.25
Book Value Per Share	1.24	1.71	3.55	5.96	12.85	25.01
Tangible Book Value	10.93	14.86	29.38	47.89	66.24	92.25
Tangible Book Value Per Share	1.24	1.71	3.53	5.93	12.79	25.01

SEC Filings: 10-K · 10-Q